Cuadro Nacional de Medicamentos Básico, una revisión y actualización del grupo terapéutico B B01A, B02AA02, B02BA01, B03AD y B03AE04

Abstract

Abstract: The objective of this work was the pharmacological analysis of technical registration sheets therapeutic of the National List of Basic Medicines, for this we worked with 14 Group B medications including: Oral solid Warfarin 1-5mg, Heparin (not fractionated) parenteral liquid 5,000 IU/mL, Enoxaparin parenteral liquid 2,000 IU - 10,000 IU (20 mg - 100 mg), Clopidogrel oral solid 75-300mg, Acetylsalicylic acid oral solid 100mg, Parenteral liquid Tirofiban 0.25 mg/mL, Oral solid Ticagrelor60-90mg, Solid parenteral streptokinase 1500,000 IU, Alteplase solid parenteral 50mg, Oral solid rivaroxaban 2.5 mg and 20 mg, parenteral liquid Tranexamic Acid 100 mg/ml and oral solid 250mg and 500mg, parenteral liquid phytomenadione 10mg/ml, Iron, multivitamins and minerals: Iron - Zinc - Vitamin A Folic acid - Oral solid ascorbic acid (powder) 12.5 mg-5mg-300 mcg- 160 mcg- 30mg and Iron Salts + Oral solid Folic Acid 60mg+400mcg. The study was specifically investigative in nature through the review of information technical and scientific in magazines, books and web pages; this with the purpose of Provide truthful information to health personnel who require the prescribed information. It should be noted that the information must be bibliographically verified and analyzed through clinical cases of problems related to medications with the purpose of Validate relevant information. As a result, 14 records of Group B medications were updated; For this, the protocol for preparing therapeutic cards was taken as a reference and guide. which is prepared by the National Health Council CONASA.